FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Merlin Robb

Research Profile

Living Beings

Disorders

HIV Infections

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Physiology

Recombination, Genetic

Co-author Network

Publications

TOP 3
Supachai Rerks-Ngarm; Merlin L Robb; Jim Tartaglia; Prasert Thongcharoen; Rapee Trichavaroj; Elizabeth Adams; Charla Andrews; Chureeratana Bowonwatanuwong; Supamit Chunsutthiwat; Nampueng Churikanont; Mark de Souza; Chirapa Eamsila; Jorge Flores; Donald Francis; Peter B Gilbert; Sanjay Gurunathan; Jaranit Kaewkungkal; Prayura Kunasol; Shuying S Li; Nelson L Michael; Chawetsan Namwat; Viseth Ngauy; Sorachai Nitayaphan; Robert J O'Connell; Robert M Paris; Nakorn Premsri; Jerome H Kim
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
Michael A Eller; David Guwatudde; Vicky Lo; Mary A Marovich; Nelson L Michael; Barbara Nails; Benson J Ouma; Silvia Ratto-Kim; Merlin L Robb; Johan K Sandberg; Fred Wabwire-Mangen; Mark de Souza; Leigh Anne Eller; Jeffrey R Currier
Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
Dan H Barouch; Erik A Billings; Angela Carville; Guido Ferrari; Donald N Forthal; Jaap Goudsmit; Vanessa M Hirsch; M Justin Iampietro; Jerome H Kim; Hualin Li; Jinyan Liu; Diana M Lynch; Keith G Mansfield; Mary A Marovich; Lori F Maxfield; Ilnour Ourmanov; Maria G Pau; Mangala Rao; Merlin L Robb; Jerald C Sadoff; Adam SanMiguel; Hanneke Schuitemaker; Michael S Seaman; Donald Stablein; peter abbink; Nelson L Michael
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Merlin Robb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Supachai Rerks-Ngarm; Merlin L Robb; Jim Tartaglia; Prasert Thongcharoen; Rapee Trichavaroj; Elizabeth Adams; Charla Andrews; Chureeratana Bowonwatanuwong; Supamit Chunsutthiwat; Nampueng Churikanont; Mark de Souza; Chirapa Eamsila; Jorge Flores; Donald Francis; Peter B Gilbert; Sanjay Gurunathan; Jaranit Kaewkungkal; Prayura Kunasol; Shuying S Li; Nelson L Michael; Chawetsan Namwat; Viseth Ngauy; Sorachai Nitayaphan; Robert J O'Connell; Robert M Paris; Nakorn Premsri; Jerome H Kim
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
The Journal of infectious diseases 2013;207(8):1195-205.
2012: Michael A Eller; David Guwatudde; Vicky Lo; Mary A Marovich; Nelson L Michael; Barbara Nails; Benson J Ouma; Silvia Ratto-Kim; Merlin L Robb; Johan K Sandberg; Fred Wabwire-Mangen; Mark de Souza; Leigh Anne Eller; Jeffrey R Currier
Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
Journal of acquired immune deficiency syndromes (1999) 2012;61(1):9-18.
2012: Dan H Barouch; Erik A Billings; Angela Carville; Guido Ferrari; Donald N Forthal; Jaap Goudsmit; Vanessa M Hirsch; M Justin Iampietro; Jerome H Kim; Hualin Li; Jinyan Liu; Diana M Lynch; Keith G Mansfield; Mary A Marovich; Lori F Maxfield; Ilnour Ourmanov; Maria G Pau; Mangala Rao; Merlin L Robb; Jerald C Sadoff; Adam SanMiguel; Hanneke Schuitemaker; Michael S Seaman; Donald Stablein; peter abbink; Nelson L Michael
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.
Nature 2012;482(7383):89-93.
2012: Silvia Ratto-Kim; Merlin L Robb; Eddy Sayeed; Doris Thelian; Anais Valencia-Micolta; Josephine H Cox; Jeffrey R Currier; Patricia L Earl; Jean-Louis Excler; Jerome H Kim; Vicky Lo; Nelson L Michael; Bernard Moss; Victoria R Polonis; Mary A Marovich
Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.
PloS one 2012;7(9):e45840.
2011: Steffen Geis; Christof Geldmacher; Deborah L Birx; Oliver Hoffmann; Leonard Maboko; Nelson L Michael; Donan Mmbando; Merlin L Robb; Elmar Saathoff; Eleuter Samky; Michael Hoelscher
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.
Journal of acquired immune deficiency syndromes (1999) 2011;56(5):453-9.
2011: Jeffrey R Currier; Nelson L Michael; Merlin L Robb; Mary A Marovich
Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.
Journal of translational medicine 2011;9():212.
2011: Michael A Eller; Emil Lesho; Josephine H Cox; Jeffrey R Currier; Janice M Darden; Nelson L Michael; Sheila Peel; Victoria R Polonis; Merlin L Robb; Bonnie M Slike; Maryanne Vahey; Zhining Wang; Mary A Marovich
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.
PloS one 2011;6(9):e24254.
2011: Peter Oballah; Benson Ouma; Merlin L Robb; Fred Wabwire-Mangen; Bruce K Brown; Mark de Souza; Leigh Anne Eller; Michael A Eller; Britta Flach; Hannah N Kibuuka; Nelson L Michael; David Montefiori; Victoria R Polonis
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.
PloS one 2011;6(8):e22653.
2011: Michael A Eller; Kim G Blom; Veronica D Gonzalez; Leigh Anne Eller; Prossy Naluyima; Oliver Laeyendecker; Thomas C Quinn; Noah Kiwanuka; David Serwadda; Nelson K Sewankambo; Boonrat Tasseneetrithep; Maria J Wawer; Ronald H Gray; Mary A Marovich; Nelson L Michael; Mark de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
PloS one 2011;6(4):e18779.
2010: Elmar Saathoff; Michael Pritsch; Christof Geldmacher; Oliver Hoffmann; Rebecca N Koehler; Leonard Maboko; Lucas Maganga; Steffen Geis; Francine E McCutchan; Gustavo H Kijak; Jerome H Kim; Miguel A Arroyo; Martina Gerhardt; Sodsai Tovanabutra; Merlin L Robb; Carolyn Williamson; Nelson L Michael; Michael Hoelscher
Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.
Journal of acquired immune deficiency syndromes (1999) 2010;54(3):324-30.
2010: Douglas N Shaffer; Ignatius K Ngetich; Christian T Bautista; Frederick K Sawe; Philip O Renzullo; Paul T Scott; Rukia M Kibaya; Kennedy O Imbuki; Nelson L Michael; Deborah L Birx; Monique K Wasunna; Merlin L Robb
HIV-1 incidence rates and risk factors in agricultural workers and dependents in rural Kenya: 36-month follow-up of the Kericho HIV cohort study.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):514-21.
2010: Hannah Kibuuka; Robert Kimutai; Leonard Maboko; Fred Sawe; Mirjam S Schunk; Arne Kroidl; Douglas Shaffer; Leigh Anne Eller; Rukia Kibaya; Michael A Eller; Karin B Schindler; Alexandra Schuetz; Monica Millard; Jason Kroll; Len Dally; Michael Hoelscher; Robert Bailer; Josephine H Cox; Mary Marovich; Deborah L Birx; Barney S Graham; Nelson L Michael; Mark de Souza; Merlin L Robb
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
The Journal of infectious diseases 2010;201(4):600-7.
2008: Merlin L Robb
Failure of the Merck HIV vaccine: an uncertain step forward.
Lancet 2008;372(9653):1857-8.
2008: Gustavo H Kijak; Luiz Mario Janini; Sodsai Tovanabutra; eric sanders-buell; Miguel Angel Arroyo; Merlin L Robb; Nelson L Michael; Deborah L Birx; Francine E McCutchan
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.
Virology 2008;376(1):101-11.
2008: Bruce K Brown; Lindsay Wieczorek; eric sanders-buell; Andrew Rosa Borges; Merlin L Robb; Deborah L Birx; Nelson L Michael; Francine E McCutchan; Victoria R Polonis
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Virology 2008;375(2):529-38.
2008: Rukia S Kibaya; Christian T Bautista; Frederick K Sawe; Douglas N Shaffer; Warren B Sateren; Paul T Scott; Nelson L Michael; Merlin L Robb; Deborah L Birx; Mark de Souza
Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya.
PloS one 2008;3(10):e3327.
2007: Michael A Eller; Leigh Anne Eller; Marc S Opollo; Benson J Ouma; Peter Ouma Oballah; Lynee Galley; Chitraporn Karnasuta; Silvia Ratto Kim; Merlin L Robb; Nelson L Michael; Hannah Kibuuka; Fred Wabwire-Mangen; Barney S Graham; Deborah L Birx; Mark de Souza; Josephine H Cox
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
Vaccine 2007;25(45):7737-42.
2007: Leigh Anne Eller; Michael A Eller; Benson J Ouma; Peter Kataaha; Bernard S Bagaya; Robert L Olemukan; Simon Erima; Lilian Kawala; Mark de Souza; Hannah Kibuuka; Fred Wabwire-Mangen; Sheila A Peel; Robert J O'Connell; Merlin L Robb; Nelson L Michael
Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population.
Journal of clinical microbiology 2007;45(10):3281-5.
2007: Douglas N Shaffer; Christian T Bautista; Warren B Sateren; Frederick K Sawe; Stanley C Kiplangat; Argwings O Miruka; Philip O Renzullo; Paul T Scott; Merlin L Robb; Nelson L Michael; Deborah L Birx
The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the Kericho HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):371-9.
2007: Sodsai Tovanabutra; Gustavo H Kijak; CHRISTOPHER BEYRER; Christiana Gammon-Richardson; Supachai Sakkhachornphop; Tasanai Vongchak; Jaroon Jittiwutikarn; Myat Htoo Razak; eric sanders-buell; Merlin L Robb; Vinai Suriyanon; Deborah L Birx; Nelson L Michael; David Celentano; Francine E McCutchan
Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.
AIDS research and human retroviruses 2007;23(6):829-33.
2007: Sodsai Tovanabutra; Mark de Souza; Nopporn Sittisombut; Somchai Sriplienchan; Vidhaya Ketsararat; Deborah L Birx; Chirasak Khamboonrueng; Kenrad E Nelson; Francine E McCutchan; Merlin L Robb
HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE.
AIDS (London, England) 2007;21(8):1050-3.
2007: Gustavo H Kijak; Mario Janini; Sodsai Tovanabutra; eric sanders-buell; Deborah L Birx; Merlin L Robb; Nelson L Michael; Francine E McCutchan
HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.
AIDS research and human retroviruses 2007;23(4):554-7.
2007: Gustavo H Kijak; Sodsai Tovanabutra; eric sanders-buell; Veerachai Watanaveeradej; Mark de Souza; Kenrad E Nelson; Vidhaya Ketsararat; Vilawan Gulgolgarn; Manu Wera-arpachai; Somchai Sriplienchan; Chirasak Khamboonrueng; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.
Virology 2007;358(1):178-91.
2006: Miguel A Arroyo; Warren B Sateren; David Serwadda; Ronald H Gray; Maria J Wawer; Nelson K Sewankambo; Noah Kiwanuka; Godfrey Kigozi; Fred Wabwire-Mangen; Michael A Eller; Leigh Anne Eller; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.
Journal of acquired immune deficiency syndromes (1999) 2006;43(4):440-5.
2006: Veerachai Watanaveeradej; Michael W Benenson; Mark De Souza; Narongrid Sirisopana; Sorachai Nitayaphan; Chalermsri Tontichaivanich; Ramase Amphaipit; Philip O Renzullo; Arthur E Brown; John G McNeil; Merlin L Robb; Deborah L Birx; Sodsai Tovanabutra; Jean K Carr; Francine E McCutchan
Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.
AIDS research and human retroviruses 2006;22(8):801-7.
2006: Unchalee Visawapoka; Sodsai Tovanabutra; Jeffrey R Currier; Josephine H Cox; Carl Mason; Monique Wasunna; Mathurose Ponglikitmongkol; William E Dowling; Merlin L Robb; Deborah L Birx; Francine E McCutchan
Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.
AIDS research and human retroviruses 2006;22(7):695-702.
2005: Darrell E Singer; Noah Kiwanuka; David Serwadda; Fred Nalugoda; Linda Hird; Jamie Bulken-Hoover; Godfrey Kigozi; Jennifer A Malia; Eva K Calero; Warren B Sateren; Merlin L Robb; Fred Wabwire-Mangen; Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; Deborah L Birx; Nelson L Michael
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
Journal of clinical microbiology 2005;43(10):5312-5.
2004: Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren B Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.
Journal of clinical microbiology 2004;42(8):3850-2.
2004: Gustavo H Kijak; eric sanders-buell; Nathan D Wolfe; Eitel Mpoudi-Ngole; Bohye Kim; Bruce Brown; Merlin L Robb; Deborah L Birx; Donald S. Burke; Jean K Carr; Francine E McCutchan
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa.
AIDS research and human retroviruses 2004;20(5):521-30.
2004: Sodsai Tovanabutra; CHRISTOPHER BEYRER; Supachai Sakkhachornphop; Myat Htoo Razak; Gabriela L Ramos; Tasanai Vongchak; Kittipong Rungruengthanakit; Pongpran Saokhieo; Kwanchanok Tejafong; Bohye Kim; Mark de Souza; Merlin L Robb; Deborah L Birx; Jaroon Jittiwutikarn; Vinai Suriyanon; David Celentano; Francine E McCutchan
The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002.
AIDS research and human retroviruses 2004;20(5):465-75.
2003: Iqbal H Chowdhury; Arash Farhadi; Xiao-Fan Wang; Merlin L Robb; Deborah L Birx; Jerome H Kim
Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
International journal of cancer. Journal international du cancer 2003;107(4):603-11.
2003: Jeffrey R Currier; William E Dowling; K Monique Wasunna; Uzma Alam; Carl Mason; Merlin L Robb; Jean K Carr; Francine E McCutchan; Deborah L Birx; Josephine H Cox
Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans.
AIDS (London, England) 2003;17(15):2149-57.
2003: Jerome H Kim; Punnee Pitisuttithum; Chirasak Kamboonruang; Thippawan Chuenchitra; John R Mascola; Sarah Schlesinger Frankel; Mark de Souza; Victoria R Polonis; Robert McLinden; Anna Sambor; Arthur E Brown; Benjaluck Phonrat; Kittipong Rungruengthanakit; Anne-Marie Duliege; Merlin L Robb; John McNeil; Deborah L Birx
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
AIDS research and human retroviruses 2003;19(9):807-16.
2003: Victoria R Polonis; Mark de Souza; Janice M Darden; Somsak Chantakulkij; Thippawan Chuenchitra; Sorachai Nitayaphan; Arthur E Brown; Merlin L Robb; Deborah L Birx
Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.
Journal of virology 2003;77(15):8570-6.
2003: Sodsai Tovanabutra; Veerachai Watanaveeradej; Kwanjai Viputtikul; Mark de Souza; Myat Htoo Razak; Vinai Suriyanon; Jaroon Jittiwutikarn; Somchai Sriplienchan; Sorachai Nitayaphan; Michael W Benenson; Narongrid Sirisopana; Philip O Renzullo; Arthur E Brown; Merlin L Robb; CHRISTOPHER BEYRER; David Celentano; John G McNeil; Deborah L Birx; Jean K Carr; Francine E McCutchan
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand.
AIDS research and human retroviruses 2003;19(7):561-7.
2003: Iqbal H Chowdhury; Xiao-Fan Wang; Nathaniel R Landau; Merlin L Robb; Victoria R Polonis; Deborah L Birx; Jerome H Kim
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest.
Virology 2003;305(2):371-7.
2002: Matthew E Harris; David Serwadda; Nelson K Sewankambo; Bohye Kim; Godfrey Kigozi; Noah Kiwanuka; James B Phillips; Fred Wabwire; Mary Meehen; Tom Lutalo; James R Lane; Randall Merling; Ronald H Gray; Maria J Wawer; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate.
AIDS research and human retroviruses 2002;18(17):1281-90.
2002: Mary A Marovich; John R Mascola; Michael A Eller; Mark K Louder; Pierre A Caudrelier; Raphaelle El Habib; Silvia Ratto-Kim; Josephine H Cox; Jeffrey R Currier; Bruce L Levine; Carl H June; Wendy B Bernstein; Merlin L Robb; Beatrice Schuler-Thurner; Ralph M Steinman; Deborah L Birx; Sarah Schlesinger-Frankel
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells.
The Journal of infectious diseases 2002;186(9):1242-52.
2002: Michael Hoelscher; William E Dowling; eric sanders-buell; Jean K Carr; Matthew E Harris; Angelika Thomschke; Merlin L Robb; Deborah L Birx; Francine E McCutchan
Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay.
AIDS (London, England) 2002;16(15):2055-64.
2002: William E Dowling; Bohye Kim; Carl Mason; K Monique Wasunna; Uzma Alam; Lynne Elson; Deborah L Birx; Merlin L Robb; Francine E McCutchan; Jean K Carr
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants.
AIDS (London, England) 2002;16(13):1809-20.
2001: Jerome H Kim; John R Mascola; Silvia Ratto-Kim; Thomas C VanCott; Lawrence D Loomis-Price; Josephine H Cox; Nelson L Michael; Linda L Jagodzinski; C Hawkes; DL Mayers; Bruce L Gilliam; D C Birx; Merlin L Robb
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.
AIDS research and human retroviruses 2001;17(11):1021-34.
2001: Mark de Souza; Rapee Trichavaroj; Somchai Sriplienchan; Puangmalee Buapunth; Philip O Renzullo; Cheodchai Chuenchitra; Deborah L Birx; Merlin L Robb; Arthur E Brown
Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects.
AIDS research and human retroviruses 2001;17(3):229-32.
2000: Mika Salminen; Philip K Ehrenberg; John R Mascola; Debora Elizabeth Sites (Dayhoff); R Merling; B Blake; Mark K Louder; S Hegerich; Victoria R Polonis; Deborah L Birx; Merlin L Robb; Francine E McCutchan; Nelson L Michael
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.
Virology 2000;278(1):103-10.
2000: Shuenn-Jue Wu; G Grouard-Vogel; Wellington Sun; John R Mascola; Elena F Brachtel; R Putvatana; Mark K Louder; Luis Filgueira; Mary A Marovich; Henry K Wong; Andrew Blauvelt; Gerald S Murphy; Merlin L Robb; B L Innes; Deborah L Birx; Curtis G Hayes; Sarah Schlesinger Frankel
Human skin Langerhans cells are targets of dengue virus infection.
Nature medicine 2000;6(7):816-20.
2000: Rutt Chuachoowong; Nathan Shaffer; Thomas C VanCott; Pongsakdi Chaisilwattana; W Siriwasin; Naris Waranawat; Nirun Vanprapar; Nancy L Young; Timothy Mastro; John S Lambert; Merlin L Robb
Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
The Journal of infectious diseases 2000;181(6):1957-63.
2000: Francine E McCutchan; K Viputtigul; Mark de Souza; Jean K Carr; Lauri E Markowitz; Puangmalee Buapunth; John G McNeil; Merlin L Robb; Sorachai Nitayaphan; Deborah L Birx; Arthur E Brown
Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand.
AIDS research and human retroviruses 2000;16(8):801-5.
1999: Shizuko Sei; S L Sandelli; Georgia Theofan; Silvia Ratto-Kim; M Kumagai; Lawrence D Loomis-Price; Josephine H Cox; Paul F Jarosinski; C M Walsek; Pim Brouwers; DJ Venzon; J Xu; PA Pizzo; Ronald B Moss; Merlin L Robb; Lauren V Wood
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection.
The Journal of infectious diseases 1999;180(3):626-40.
1999: Nelson L Michael; S A Herman; S Kwok; K Dreyer; J Wang; C Christopherson; JP Spadoro; K K Young; Victoria R Polonis; F E McCutchan; Jean K Carr; John R Mascola; Linda L Jagodzinski; Merlin L Robb
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.
Journal of clinical microbiology 1999;37(8):2557-63.
1999: Thomas C VanCott; John R Mascola; Lawrence D Loomis-Price; F Sinangil; N Zitomersky; John McNeil; Merlin L Robb; Deborah L Birx; S Barnett
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope.
Journal of virology 1999;73(6):4640-50.
1999: John R Mascola; Mark G Lewis; Gabriela Stiegler; D Harris; Thomas C VanCott; D Hayes; Mark K Louder; C R Brown; Christine V Sapan; Sarah Schlesinger Frankel; Y Lu; Merlin L Robb; H Katinger; Deborah L Birx
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.
Journal of virology 1999;73(5):4009-18.
1999: KV Sitz; Silvia Ratto-Kim; A S Hodgkins; Merlin L Robb; Deborah L Birx
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls.
The Journal of infectious diseases 1999;179(4):817-24.
1999: CHRISTOPHER BEYRER; Andrew W Artenstein; Sungwal Rugpao; H Stephens; Thomas C VanCott; Merlin L Robb; M Rinkaew; Deborah L Birx; Chirasak Khamboonruang; Peter Zimmerman; Kenrad E Nelson; Chawalit Natpratan
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.
The Journal of infectious diseases 1999;179(1):59-67.
1998: Sarah Schlesinger Frankel; Ralph M Steinman; Nelson L Michael; S R Kim; N Bhardwaj; Melissa Pope; Mark K Louder; Philip K Ehrenberg; P W Parren; D R Burton; H Katinger; Thomas C VanCott; Merlin L Robb; Deborah L Birx; John R Mascola
Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.
Journal of virology 1998;72(12):9788-94.
1998: Lawrence D Loomis-Price; Josephine H Cox; John R Mascola; Thomas C VanCott; Nelson L Michael; T R Fouts; Robert R Redfield; Merlin L Robb; B Wahren; H W Sheppard; Deborah L Birx
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.
The Journal of infectious diseases 1998;178(5):1306-16.
1997: John R Mascola; Mark K Louder; Thomas C VanCott; Christine V Sapan; John S Lambert; L R Muenz; B Bunow; Deborah L Birx; Merlin L Robb
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.
Journal of virology 1997;71(10):7198-206.
1997: Andrew W Artenstein; Thomas C VanCott; KV Sitz; Merlin L Robb; KF Wagner; S C Veit; A F Rogers; Robin P Garner; J W Byron; P R Burnett; Deborah L Birx
Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.
The Journal of infectious diseases 1997;175(2):265-71.
1996: Shizuko Sei; S K Stewart; M Farley; BU Mueller; J R Lane; Merlin L Robb; Pim Brouwers; PA Pizzo
Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy.
The Journal of infectious diseases 1996;174(6):1200-6.
1995: Andrew W Artenstein; Thomas C VanCott; John R Mascola; Jean K Carr; P A Hegerich; J Gaywee; eric sanders-buell; Merlin L Robb; Debora Elizabeth Sites (Dayhoff); S Thitivichianlert
Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans.
The Journal of infectious diseases 1995;171(4):805-10.
1992: Merlin L Robb; V Polonis; Maryanne Vahey; Suzanne Gartner; Nelson L Michael; A Fowler; Robert R Redfield
HIV neutralization assay using polymerase chain reaction-derived molecular signals.
Journal of acquired immune deficiency syndromes 1992;5(12):1224-9.